Travel vaccination recommendations and infection risk in HIV-positive travellers

Chang, Lisa; Lim, Bryan Chang Wei; Flaherty, Gerard; Torresi, Joseph

doi:10.1093/jtm/taz034

Cited by 22 publications

(16 citation statements)

References 139 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Patients living with HIV infection suffer from more respiratory illnesses than HIV-negative individuals [81]. Case series of COVID-19 in patients living with HIV are lacking.…”

Section: Rheumatic Disease and Immunosuppressed Patientsmentioning

confidence: 99%

COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations

Flaherty

Hession

Liew

et al. 2020

Trop Dis Travel Med Vaccines

Self Cite

View full text Add to dashboard Cite

Background: A high burden of severe disease and death from the coronavirus disease 2019 (COVID-19) has been consistently observed in older patients, especially those with pre-existing medical co-morbidities. The global pandemic lockdown has isolated many patients with chronic illnesses from their routine medical care. This narrative review article analyses the multitude of issues faced by individuals with underlying medical conditions during the COVID-19 pandemic. Methods: Sources for this publication were identified through searches of PubMed for articles published between 31st December 2019 and 4th June 2020, using combinations of search terms. Guidelines and updates from reputable agencies were also consulted. Only articles published in the English language were included. Results: The volume of literature on COVID-19 continues to expand, with 17,845 articles indexed on PubMed by 4th June 2020, 130 of which were deemed particularly relevant to the subject matter of this review. Older patients are more likely to progress to severe COVID-19 disease requiring intensive care unit (ICU) admission. Patients with preexisting cardiovascular disease, especially hypertension and coronary heart disease, are at greatly increased risk of developing severe and fatal COVID-19 disease. A controversial aspect of the management of COVID-19 disease has been the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Obese COVID-19 patients are more likely to require complex ICU management. Putative mechanisms of increased COVID-19 disease severity in diabetes include hyperglycaemia, altered immune function, sub-optimal glycaemic control during hospitalisation, a pro-thrombotic and pro-inflammatory state. Patients with mental health disorders are particularly vulnerable to social isolation, and this has been compounded by the suspension of non-emergency care in hospitals around the world, making it difficult for patients with chronic mental illness to attend outpatient appointments.

show abstract

“…Patients living with HIV infection suffer from more respiratory illnesses than HIV-negative individuals [81]. Case series of COVID-19 in patients living with HIV are lacking.…”

Section: Rheumatic Disease and Immunosuppressed Patientsmentioning

confidence: 99%

COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations

Flaherty

Hession

Liew

et al. 2020

Trop Dis Travel Med Vaccines

Self Cite

View full text Add to dashboard Cite

show abstract

“…Because of the single case of fatal encephalomyelitis after YF vaccination in a man with previously undiagnosed HIV, 33 most guidelines recommend against YF vaccination in HIV-POS patients with CD4 counts < 200 cells/μl. 52 , 53 Although YF vaccination generally induces lower neutralizing antibody titres that decline more rapidly than in HIV-NEG individuals, the long-term immune response to YFV (up to 10 years) in patients taking combination antiretroviral therapy and who had suppressed HIV viral loads at the time of vaccination, is comparable to HIV-NEG subjects. 53 , 54 …”

Section: Discussionmentioning

confidence: 99%

A clinician’s perspective on yellow fever vaccine-associated neurotropic disease

Lecomte

Lochard

Verbeke

et al. 2020

Journal of Travel Medicine

View full text Add to dashboard Cite

Yellow fever (YF) causes high fever, liver dysfunction, renal failure, hypercoagulopathy and platelet dysfunction and can lead to shock and death with a case-fatality ratio of 20 to 50%. Yellow fever vaccination results in long-lasting protective immunity. Serious adverse events, such as yellow fever vaccine-associated neurotropic disease (YEL-AND) are rare. We present a case of a 56-year-old Caucasian man with fever, headache, cognitive problems at the emergency department. He received a primary yellow fever vaccination 4 weeks prior to symptom onset. Cerebrospinal fluid tested positive for YF virus by RT-PCR and confirmed diagnosis of YEL-AND. The patient recovered with symptomatic treatment. We reviewed published clinical reports on YEL-AND indexed for MEDLINE. We identified and analyzed 53 case reports. Forty-five patients were male and eight were female. Twenty-nine cases met criteria for definite YEL-AND and twenty-four for suspected YEL-AND according to Yellow Fever Vaccine Safety Working Group. We applied the Brighton Collaboration diagnostic criteria to assess the diagnostic accuracy of the clinical diagnoses and found meningoencephalitis in 38 reported YEL-AND cases, Guillain Barré Syndrome (GBS) in 7, Acute Disseminated Encephalomyelitis (ADEM) in 6 and myelitis in 5. Thirty-five patients recovered or improved; however, not all cases had a complete follow-up. The prognosis of YEL-AND presenting with GBS, ADEM or myelitis was poor. Fourteen patients received therapy (corticosteroids, intravenous immunoglobulins and/or plasmapheresis). In conclusion, Yellow fever vaccine-associated neurotropic disease is a very rare but serious adverse event after yellow fever vaccination. We described a case of YEL-AND and propose a standardized clinical workup of this condition based on a review of the literature. Centralized registration of complications of yellow fever vaccination is encouraged.

show abstract

“…Publikationen der STIKO geben Anwendungshinweise zu den EmpfehlungenimKontextvonImmundefizienz [10][11][12][13].…”

Section: Impfungen Bei Immunsuppressionunclassified

Reiseimpfungen – Hinweise und Empfehlungen

Rothe

Rosenbusch

Alberer

et al. 2021

Flugmedizin · Tropenmedizin · Reisemedizin - FTR

View full text Add to dashboard Cite

Travel vaccination recommendations and infection risk in HIV-positive travellers

Cited by 22 publications

References 139 publications

COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations

COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations

A clinician’s perspective on yellow fever vaccine-associated neurotropic disease

Reiseimpfungen – Hinweise und Empfehlungen

Contact Info

Product

Resources

About